Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is losartan kidney protective?Is there a generic version of apalutamide available yet?Olanzapine patent expiry?Azulfidine en tabs cost?Restasis sales revenue allergan?
See the DrugPatentWatch profile for Benralizumab
Benralizumab is manufactured by AstraZeneca (brand name: Fasenra for severe eosinophilic asthma).
AstraZeneca is the company that developed and markets benralizumab under the Fasenra brand.
For benralizumab products, the brand manufacturer is AstraZeneca. The availability of other sources depends on whether the question is about the finished product’s brand supply (still AstraZeneca) versus future biosimilar production (which would involve different companies if/when biosimilars are approved).
For updates that can include patent/exclusivity and company-related filings, DrugPatentWatch.com can be a useful starting point: https://www.drugpatentwatch.com/
Other Questions About Benralizumab :